{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,3,24]],"date-time":"2026-03-24T17:43:03Z","timestamp":1774374183478,"version":"3.50.1"},"reference-count":57,"publisher":"Frontiers Media SA","content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Pediatr."],"DOI":"10.3389\/fped.2015.00078","type":"journal-article","created":{"date-parts":[[2015,9,28]],"date-time":"2015-09-28T09:25:04Z","timestamp":1443432304000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":20,"title":["The Evidence-Based Approach to Adult-Onset Idiopathic Nephrotic Syndrome"],"prefix":"10.3389","volume":"3","author":[{"given":"Pietro A. A.","family":"Canetta","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jai","family":"Radhakrishnan","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"1965","published-online":{"date-parts":[[2015,9,25]]},"reference":[{"issue":"3","key":"B1","doi-asserted-by":"publisher","first-page":"335","DOI":"10.1053\/j.ajkd.2011.06.006","article-title":"Trial quality in nephrology: how are we measuring up?","volume":"58","author":"Palmer","year":"2011","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"B2","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1053\/j.ackd.2012.01.009","article-title":"Randomized controlled trials in nephrology: state of the evidence and critiquing the evidence","volume":"19","author":"Samuels","year":"2012","journal-title":"Adv Chronic Kidney Dis"},{"issue":"4","key":"B3","doi-asserted-by":"publisher","first-page":"337","DOI":"10.1038\/ki.2010.156","article-title":"Glomerular disease: why is there a dearth of high quality clinical trials?","volume":"78","author":"Leaf","year":"2010","journal-title":"Kidney Int"},{"issue":"2","key":"B4","doi-asserted-by":"publisher","first-page":"411","DOI":"10.1097\/01.ASN.0000100125.21491.46","article-title":"The number, quality, and coverage of randomized controlled trials in nephrology","volume":"15","author":"Strippoli","year":"2004","journal-title":"J Am Soc Nephrol"},{"issue":"2","key":"B5","doi-asserted-by":"publisher","first-page":"139","DOI":"10.1038\/kisup.2012","article-title":"KDIGO clinical practice guideline for glomerulonephritis","volume":"2","author":"Kidney Disease Improving Global Outcomes Glomerulonephritis Work Group","year":"2012","journal-title":"Kidney Int Suppl"},{"issue":"3","key":"B6","doi-asserted-by":"publisher","first-page":"CD001533","DOI":"10.1002\/14651858.CD001533.pub5","article-title":"Corticosteroid therapy for nephrotic syndrome in children","author":"Hahn","year":"2015","journal-title":"Cochrane Database Syst Rev"},{"issue":"12","key":"B7","doi-asserted-by":"publisher","first-page":"CD005425","DOI":"10.1002\/14651858.CD005425.pub2","article-title":"Lipid-lowering agents for nephrotic syndrome","author":"Kong","year":"2013","journal-title":"Cochrane Database Syst Rev"},{"issue":"11","key":"B8","doi-asserted-by":"publisher","first-page":"CD003594","DOI":"10.1002\/14651858.CD003594.pub4","article-title":"Interventions for idiopathic steroid-resistant nephrotic syndrome in children","author":"Hodson","year":"2010","journal-title":"Cochrane Database Syst Rev"},{"issue":"7182","key":"B9","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1136\/bmj.318.7182.527","article-title":"Clinical guidelines: potential benefits, limitations, and harms of clinical guidelines","volume":"318","author":"Woolf","year":"1999","journal-title":"BMJ"},{"issue":"6","key":"B10","doi-asserted-by":"crossref","first-page":"765","DOI":"10.1038\/ki.1981.209","article-title":"Primary nephrotic syndrome in children: clinical significance of histopathologic variants of minimal change and of diffuse mesangial hypercellularity. A Report of the International Study of Kidney Disease in Children","volume":"20","author":"International Study of Kidney Disease in Children","year":"1981","journal-title":"Kidney Int"},{"issue":"6","key":"B11","doi-asserted-by":"publisher","first-page":"1107","DOI":"10.1053\/j.ajkd.2003.08.010","article-title":"Is there really an increase in non-minimal change nephrotic syndrome in children?","volume":"42","author":"Filler","year":"2003","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"B12","doi-asserted-by":"publisher","first-page":"1885","DOI":"10.1046\/j.1523-1755.1999.00408.x","article-title":"Changing patterns in the histopathology of idiopathic nephrotic syndrome in children","volume":"55","author":"Bonilla-Felix","year":"1999","journal-title":"Kidney Int"},{"issue":"5","key":"B13","doi-asserted-by":"publisher","first-page":"621","DOI":"10.1016\/S0272-6386(97)90485-6","article-title":"Changing etiologies of unexplained adult nephrotic syndrome: a comparison of renal biopsy findings from 1976-1979 and 1995-1997","volume":"30","author":"Haas","year":"1997","journal-title":"Am J Kidney Dis"},{"issue":"5","key":"B14","doi-asserted-by":"publisher","first-page":"647","DOI":"10.1016\/S0272-6386(96)90098-0","article-title":"The racial prevalence of glomerular lesions in nephrotic adults","volume":"27","author":"Korbet","year":"1996","journal-title":"Am J Kidney Dis"},{"issue":"9","key":"B15","doi-asserted-by":"publisher","first-page":"1621","DOI":"10.1007\/s00467-010-1495-0","article-title":"Hereditary nephrotic syndrome: a systematic approach for genetic testing and a review of associated podocyte gene mutations","volume":"25","author":"Benoit","year":"2010","journal-title":"Pediatr Nephrol"},{"issue":"4","key":"B16","doi-asserted-by":"publisher","first-page":"592","DOI":"10.2215\/CJN.06260614","article-title":"Spectrum of steroid-resistant and congenital nephrotic syndrome in children: the PodoNet registry cohort","volume":"10","author":"Trautmann","year":"2015","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"B17","doi-asserted-by":"publisher","first-page":"230","DOI":"10.1681\/ASN.2013111155","article-title":"Heterogeneous genetic alterations in sporadic nephrotic syndrome associate with resistance to immunosuppression","volume":"26","author":"Giglio","year":"2015","journal-title":"J Am Soc Nephrol"},{"issue":"7","key":"B18","doi-asserted-by":"publisher","first-page":"1701","DOI":"10.1681\/ASN.2014030247","article-title":"HLA-DQA1 and PLCG2 are candidate risk loci for childhood-onset steroid-sensitive nephrotic syndrome","volume":"26","author":"Gbadegesin","year":"2015","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"B19","doi-asserted-by":"publisher","first-page":"1279","DOI":"10.1681\/ASN.2014050489","article-title":"A single-gene cause in 29.5% of cases of steroid-resistant nephrotic syndrome","volume":"26","author":"Sadowski","year":"2015","journal-title":"J Am Soc Nephrol"},{"issue":"5","key":"B20","doi-asserted-by":"publisher","first-page":"1139","DOI":"10.2215\/CJN.05260610","article-title":"Clinical utility of genetic testing in children and adults with steroid-resistant nephrotic syndrome","volume":"6","author":"Sant\u00edn","year":"2011","journal-title":"Clin J Am Soc Nephrol"},{"issue":"11","key":"B21","doi-asserted-by":"publisher","first-page":"2192","DOI":"10.1093\/oxfordjournals.ndt.a027136","article-title":"Long-term outcome of adult-onset minimal-change nephropathy","volume":"11","author":"Mak","year":"1996","journal-title":"Nephrol Dial Transplant"},{"issue":"6","key":"B22","doi-asserted-by":"publisher","first-page":"1215","DOI":"10.1038\/ki.1986.130","article-title":"Adult-onset minimal change nephrotic syndrome: a long-term follow-up","volume":"29","author":"Nolasco","year":"1986","journal-title":"Kidney Int"},{"issue":"7","key":"B23","doi-asserted-by":"publisher","first-page":"1316","DOI":"10.1093\/ndt\/gfg134","article-title":"Idiopathic minimal change nephrotic syndrome in older adults: steroid responsiveness and pattern of relapses","volume":"18","author":"Tse","year":"2003","journal-title":"Nephrol Dial Transplant"},{"issue":"5","key":"B24","doi-asserted-by":"publisher","first-page":"710","DOI":"10.1053\/j.ajkd.2014.09.022","article-title":"Long-term outcome of biopsy-proven minimal change nephropathy in Chinese adults","volume":"65","author":"Szeto","year":"2015","journal-title":"Am J Kidney Dis"},{"issue":"3","key":"B25","doi-asserted-by":"publisher","first-page":"445","DOI":"10.2215\/CJN.03531006","article-title":"Adult minimal-change disease: clinical characteristics, treatment, and outcomes","volume":"2","author":"Waldman","year":"2007","journal-title":"Clin J Am Soc Nephrol"},{"issue":"1","key":"B26","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1681\/ASN.2012070646","article-title":"Extending prednisolone treatment does not reduce relapses in childhood nephrotic syndrome","volume":"24","author":"Teeninga","year":"2013","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"B27","doi-asserted-by":"publisher","first-page":"217","DOI":"10.1038\/ki.2014.240","article-title":"Extending initial prednisolone treatment in a randomized control trial from 3 to 6 months did not significantly influence the course of illness in children with steroid-sensitive nephrotic syndrome","volume":"87","author":"Sinha","year":"2015","journal-title":"Kidney Int"},{"issue":"1","key":"B28","doi-asserted-by":"publisher","first-page":"225","DOI":"10.1038\/ki.2014.260","article-title":"A multicenter randomized trial indicates initial prednisolone treatment for childhood nephrotic syndrome for two months is not inferior to six-month treatment","volume":"87","author":"Yoshikawa","year":"2015","journal-title":"Kidney Int"},{"issue":"5","key":"B29","doi-asserted-by":"publisher","first-page":"702","DOI":"10.1681\/ASN.2012070734","article-title":"The treatment of minimal change disease in adults","volume":"24","author":"Hogan","year":"2013","journal-title":"J Am Soc Nephrol"},{"issue":"8","key":"B30","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1038\/ki.2012.280","article-title":"The KDIGO practice guideline on glomerulonephritis: reading between the (guide)lines \u2013 application to the individual patient","volume":"82","author":"Radhakrishnan","year":"2012","journal-title":"Kidney Int"},{"issue":"6","key":"B31","doi-asserted-by":"publisher","first-page":"1066","DOI":"10.2215\/CJN.08880813","article-title":"Cancer risk after cyclophosphamide treatment in idiopathic membranous nephropathy","volume":"9","author":"van den Brand","year":"2014","journal-title":"Clin J Am Soc Nephrol"},{"issue":"9950","key":"B32","doi-asserted-by":"publisher","first-page":"1273","DOI":"10.1016\/S0140-6736(14)60541-9","article-title":"Rituximab for childhood-onset, complicated, frequently relapsing nephrotic syndrome or steroid-dependent nephrotic syndrome: a multicentre, double-blind, randomised, placebo-controlled trial","volume":"384","author":"Iijima","year":"2014","journal-title":"Lancet"},{"issue":"9","key":"B33","doi-asserted-by":"publisher","first-page":"2259","DOI":"10.1681\/ASN.2014080799","article-title":"Rituximab in children with steroid-dependent nephrotic syndrome: a multicenter, open-label, noninferiority, randomized controlled trial","volume":"26","author":"Ravani","year":"2015","journal-title":"J Am Soc Nephrol"},{"issue":"11","key":"B34","doi-asserted-by":"publisher","first-page":"2084","DOI":"10.1093\/ndt\/gfu209","article-title":"Rituximab for minimal-change nephrotic syndrome in adulthood: predictive factors for response, long-term outcomes and tolerance","volume":"29","author":"Guitard","year":"2014","journal-title":"Nephrol Dial Transplant"},{"issue":"4","key":"B35","doi-asserted-by":"publisher","first-page":"851","DOI":"10.1093\/ndt\/gft312","article-title":"Rituximab for minimal change disease in adults: long-term follow-up","volume":"29","author":"Bruchfeld","year":"2014","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"B36","doi-asserted-by":"publisher","first-page":"511","DOI":"10.1038\/ki.2012.444","article-title":"Rituximab is an efficient and safe treatment in adults with steroid-dependent minimal change disease","volume":"83","author":"Munyentwali","year":"2013","journal-title":"Kidney Int"},{"issue":"4","key":"B37","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1681\/ASN.2013030251","article-title":"Rituximab in steroid-dependent or frequently relapsing idiopathic nephrotic syndrome","volume":"25","author":"Ruggenenti","year":"2014","journal-title":"J Am Soc Nephrol"},{"issue":"1","key":"B38","doi-asserted-by":"publisher","first-page":"96","DOI":"10.1093\/ndt\/gfu267","article-title":"Efficacy and safety of rituximab in children with difficult-to-treat nephrotic syndrome","volume":"30","author":"Sinha","year":"2015","journal-title":"Nephrol Dial Transplant"},{"issue":"25","key":"B39","doi-asserted-by":"publisher","first-page":"2398","DOI":"10.1056\/NEJMra1106556","article-title":"Focal segmental glomerulosclerosis","volume":"365","author":"D\u2019Agati","year":"2011","journal-title":"N Engl J Med"},{"issue":"2","key":"B40","first-page":"53","article-title":"The impact of prolonged immunosuppression on the outcome of idiopathic focal-segmental glomerulosclerosis with nephrotic syndrome in adults. A collaborative retrospective study","volume":"36","author":"Banfi","year":"1991","journal-title":"Clin Nephrol"},{"issue":"1","key":"B41","doi-asserted-by":"publisher","first-page":"72","DOI":"10.1053\/ajkd.1998.v32.pm9669427","article-title":"Long-term outcome in children and adults with classic focal segmental glomerulosclerosis","volume":"32","author":"Cattran","year":"1998","journal-title":"Am J Kidney Dis"},{"issue":"8","key":"B42","doi-asserted-by":"publisher","first-page":"2169","DOI":"10.1097\/01.ASN.0000135051.62500.97","article-title":"Focal segmental glomerulosclerosis in nephrotic adults: presentation, prognosis, and response to therapy of the histologic variants","volume":"15","author":"Chun","year":"2004","journal-title":"J Am Soc Nephrol"},{"issue":"6","key":"B43","doi-asserted-by":"publisher","first-page":"773","DOI":"10.1016\/S0272-6386(12)80128-4","article-title":"Primary focal segmental glomerulosclerosis: clinical course and response to therapy","volume":"23","author":"Korbet","year":"1994","journal-title":"Am J Kidney Dis"},{"issue":"4","key":"B44","doi-asserted-by":"publisher","first-page":"1061","DOI":"10.1681\/ASN.2004070593","article-title":"Toronto glomerulonephritis registry G. Focal and segmental glomerulosclerosis: definition and relevance of a partial remission","volume":"16","author":"Troyanov","year":"2005","journal-title":"J Am Soc Nephrol"},{"issue":"12","key":"B45","doi-asserted-by":"publisher","first-page":"1568","DOI":"10.1038\/ki.2008.413","article-title":"Podocyte foot process effacement as a diagnostic tool in focal segmental glomerulosclerosis","volume":"74","author":"Deegens","year":"2008","journal-title":"Kidney Int"},{"issue":"12","key":"B46","doi-asserted-by":"publisher","first-page":"1238","DOI":"10.1097\/TP.0b013e318250234a","article-title":"Podocyte foot process effacement in postreperfusion allograft biopsies correlates with early recurrence of proteinuria in focal segmental glomerulosclerosis","volume":"93","author":"Chang","year":"2012","journal-title":"Transplantation"},{"issue":"3","key":"B47","doi-asserted-by":"publisher","first-page":"271","DOI":"10.1097\/MNH.0b013e3282f94a96","article-title":"The spectrum of focal segmental glomerulosclerosis: new insights","volume":"17","author":"D\u2019Agati","year":"2008","journal-title":"Curr Opin Nephrol Hypertens"},{"issue":"1","key":"B48","doi-asserted-by":"publisher","first-page":"52","DOI":"10.1016\/S0272-6386(99)70257-X","article-title":"Absence of hypoalbuminemia despite massive proteinuria in focal segmental glomerulosclerosis secondary to hyperfiltration","volume":"33","author":"Praga","year":"1999","journal-title":"Am J Kidney Dis"},{"issue":"6","key":"B49","first-page":"213","article-title":"The long-term prognosis of patients with focal segmental glomerulosclerosis","volume":"10","author":"Cameron","year":"1978","journal-title":"Clin Nephrol"},{"issue":"4","key":"B50","doi-asserted-by":"publisher","first-page":"534","DOI":"10.1016\/0272-6386(95)90120-5","article-title":"Focal segmental glomerular sclerosis in adults: presentation, course, and response to treatment","volume":"25","author":"Rydel","year":"1995","journal-title":"Am J Kidney Dis"},{"issue":"1","key":"B51","doi-asserted-by":"publisher","first-page":"84","DOI":"10.1159\/000346256","article-title":"Tacrolimus versus cyclophosphamide in steroid-dependent or steroid-resistant focal segmental glomerulosclerosis: a randomized controlled trial","volume":"37","author":"Ren","year":"2013","journal-title":"Am J Nephrol"},{"issue":"10","key":"B52","doi-asserted-by":"publisher","first-page":"1130","DOI":"10.1038\/ki.2012.238","article-title":"Treatment with tacrolimus and prednisolone is preferable to intravenous cyclophosphamide as the initial therapy for children with steroid-resistant nephrotic syndrome","volume":"82","author":"Gulati","year":"2012","journal-title":"Kidney Int"},{"issue":"10","key":"B53","doi-asserted-by":"publisher","first-page":"1918","DOI":"10.1093\/ndt\/gfu097","article-title":"Tacrolimus therapy in adult-onset steroid-resistant nephrotic syndrome due to a focal segmental glomerulosclerosis single-center experience","volume":"29","author":"Ramachandran","year":"2014","journal-title":"Nephrol Dial Transplant"},{"issue":"3","key":"B54","doi-asserted-by":"publisher","first-page":"527","DOI":"10.1093\/ndt\/gfs563","article-title":"Impact of the National Institutes of Health Focal Segmental Glomerulosclerosis (NIH FSGS) clinical trial on the treatment of steroid-resistant FSGS","volume":"28","author":"Canetta","year":"2013","journal-title":"Nephrol Dial Transplant"},{"issue":"8","key":"B55","doi-asserted-by":"publisher","first-page":"1317","DOI":"10.2215\/CJN.00570109","article-title":"Rituximab treatment of adult patients with steroid-resistant focal segmental glomerulosclerosis","volume":"4","author":"Fernandez-Fresnedo","year":"2009","journal-title":"Clin J Am Soc Nephrol"},{"issue":"7","key":"B56","doi-asserted-by":"publisher","first-page":"759","DOI":"10.2169\/internalmedicine.51.6854","article-title":"Rituximab treatment for adult patients with focal segmental glomerulosclerosis","volume":"51","author":"Ochi","year":"2012","journal-title":"Intern Med"},{"issue":"11\u201312","key":"B57","doi-asserted-by":"publisher","first-page":"328","DOI":"10.1007\/s00508-013-0366-7","article-title":"Rituximab in adult patients with multi-relapsing\/steroid-dependent minimal change disease and focal segmental glomerulosclerosis: a report of 5 cases","volume":"125","author":"Kronbichler","year":"2013","journal-title":"Wien Klin Wochenschr"}],"container-title":["Frontiers in Pediatrics"],"original-title":[],"deposited":{"date-parts":[[2017,6,23]],"date-time":"2017-06-23T20:20:52Z","timestamp":1498249252000},"score":1,"resource":{"primary":{"URL":"http:\/\/journal.frontiersin.org\/Article\/10.3389\/fped.2015.00078\/abstract"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2015,9,25]]},"references-count":57,"URL":"https:\/\/doi.org\/10.3389\/fped.2015.00078","relation":{},"ISSN":["2296-2360"],"issn-type":[{"value":"2296-2360","type":"electronic"}],"subject":[],"published":{"date-parts":[[2015,9,25]]}}}